TERMIUM Plus®

The Government of Canada’s terminology and linguistic data bank.

ANTI-NUCLEAR AUTO-ANTIBODY [1 record]

Filter results by subject field Alphabetical list of terms

Filter results by subject field

Alphabetical list of terms

Record 1 2011-12-30

English

Subject field(s)
  • Pharmacology
CONT

Procyon has established leadership in the development of two substantial anti-cancer technology platforms with therapeutic and diagnostic applications that are based on naturally occurring cancer-fighting molecules found within the human body. These anti-cancer platforms involve Prostate Secretory Protein (PSP) and Anti-nuclear Auto-antibodies (ANAs).

French

Domaine(s)
  • Pharmacologie
CONT

Procyon BioPharma Inc. a démontré son leadership dans le développement de deux plates-formes technologiques d'envergure destinées au traitement du cancer. Il s'agit de la Protéine Sécrétoire de la Prostate (PSP94) et des Auto-Anticorps Antinucléaires (ANA), qui peuvent avoir des applications thérapeutiques ainsi qu'au niveau du diagnostic. Ces plates-formes technologiques sont fondées sur la découverte de molécules antitumorales présentes naturellement dans le corps humain.

Spanish

Save record 1

Copyright notice for the TERMIUM Plus® data bank

© Public Services and Procurement Canada, 2024
TERMIUM Plus®, the Government of Canada's terminology and linguistic data bank
A product of the Translation Bureau

Display options

Change the order of display of the official languages of Canada
Option to display the non-official languages (Spanish or Portuguese)
Display definitions, contexts, etc., on records

Features

Language Portal of Canada

Access a collection of Canadian resources on all aspects of English and French, including quizzes.

Writing tools

The Language Portal’s writing tools have a new look! Easy to consult, they give you access to a wealth of information that will help you write better in English and French.

Glossaries and vocabularies

Access Translation Bureau glossaries and vocabularies.

Date Modified: